Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target

Overview of attention for article published in Familial Cancer, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 4 X users

patent: 6 patents

Readers on

mendeley: 72 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Combination therapies for treating cancer

Grant US-12156872-B2

United States of America

03 Dec 2024

Combination therapies and uses thereof

Grant US-11801240-B2

United States of America

31 Oct 2023

Combination therapies for treating cancer with niraparib and PD-1 inhibitors

Grant US-11661453-B2

United States of America

30 May 2023

Combination therapies for treating cancer

Grant US-11622961-B2

United States of America

11 Apr 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.